메뉴 건너뛰기




Volumn 55, Issue 6, 2012, Pages 521-526

Enhanced plasma factor VIII activity in mice via cysteine mutation using dual vectors

Author keywords

coagulation activity; coagulation factor VIII; dual vector gene delivery; heavy chain secretion; inter chain disulfide bonding

Indexed keywords

B DOMAIN DELETED FACTOR VIII; B-DOMAIN-DELETED FACTOR VIII; BLOOD CLOTTING FACTOR 8; CYSTEINE; PEPTIDE FRAGMENT;

EID: 84863312568     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4333-8     Document Type: Article
Times cited : (5)

References (22)
  • 1
    • 66149099963 scopus 로고    scopus 로고
    • Comparison of factor VIII Transgenes bioengineered for improved expression in gene therapy of hemophilia A
    • Dooriss K L, Denning G, Gangadharan B, et al. Comparison of factor VIII Transgenes bioengineered for improved expression in gene therapy of hemophilia A. Hum Gene Ther, 2009, 20: 465-478.
    • (2009) Hum Gene Ther , vol.20 , pp. 465-478
    • Dooriss, K.L.1    Denning, G.2    Gangadharan, B.3
  • 2
    • 33745606715 scopus 로고    scopus 로고
    • Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs
    • Jiang H, Lillicrap D, Patarroyo-White S, et al. Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs. Blood, 2006, 108: 107-115.
    • (2006) Blood , vol.108 , pp. 107-115
    • Jiang, H.1    Lillicrap, D.2    Patarroyo-White, S.3
  • 3
    • 0033607305 scopus 로고    scopus 로고
    • Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein
    • Burton M, Nakai H, Colosi P, et al. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein. Proc Natl Acad Sci USA, 1999, 96: 12725-12730.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 12725-12730
    • Burton, M.1    Nakai, H.2    Colosi, P.3
  • 4
    • 33645908797 scopus 로고    scopus 로고
    • Long-term efficacy of adenoassociated virus serotypes 8 and 9 in hemophilia a dogs and mice
    • Sarkar R, Mucci M, Addya S, et al. Long-term efficacy of adenoassociated virus serotypes 8 and 9 in hemophilia a dogs and mice. Hum Gene Ther, 2006, 17: 427-439.
    • (2006) Hum Gene Ther , vol.17 , pp. 427-439
    • Sarkar, R.1    Mucci, M.2    Addya, S.3
  • 5
    • 0023918719 scopus 로고
    • Synthesis, processing, and secretion of recombinant human factor VI11 expressed in mammalian cell
    • Kaufman R J, Wasley L C, Dorner A J. Synthesis, processing, and secretion of recombinant human factor VI11 expressed in mammalian cell. J Biol Chem, 1988, 263: 6352-6362.
    • (1988) J Biol Chem , vol.263 , pp. 6352-6362
    • Kaufman, R.J.1    Wasley, L.C.2    Dorner, A.J.3
  • 6
    • 78751538279 scopus 로고    scopus 로고
    • The effect of a secretion-enhanced heavy chain on improving intein-based dual-vector co-delivery of a full-length factor VIII gene
    • Zhu F X, Yang S D, Liu Z L, et al. The effect of a secretion-enhanced heavy chain on improving intein-based dual-vector co-delivery of a full-length factor VIII gene. Chin Sci Bull, 2011, 56: 158-163.
    • (2011) Chin Sci Bull , vol.56 , pp. 158-163
    • Zhu, F.X.1    Yang, S.D.2    Liu, Z.L.3
  • 7
    • 33646765242 scopus 로고    scopus 로고
    • Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants
    • Gale A J, Radtke K P, Cunningham M A, et al. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants. J Thromb Haemost, 2006, 4: 1315-1322.
    • (2006) J Thromb Haemost , vol.4 , pp. 1315-1322
    • Gale, A.J.1    Radtke, K.P.2    Cunningham, M.A.3
  • 8
    • 84860864477 scopus 로고    scopus 로고
    • Disulfide cross-linking enhances dual-vector based delivery of split B-domain-deleted coagulation factor VIII gene
    • Zhu F X, Yang S D, Liu Z L, et al. Disulfide cross-linking enhances dual-vector based delivery of split B-domain-deleted coagulation factor VIII gene. Prog Biochem Biophys, 2012, 39: 181-187.
    • (2012) Prog Biochem Biophys , vol.39 , pp. 181-187
    • Zhu, F.X.1    Yang, S.D.2    Liu, Z.L.3
  • 9
    • 77954299403 scopus 로고    scopus 로고
    • Protein trans-splicing based dualvector delivery of the coagulation factor VIII gene
    • Zhu F X, Liu Z L, Chi X Y, et al. Protein trans-splicing based dualvector delivery of the coagulation factor VIII gene. Sci China Life Sci, 2010, 53: 683-689.
    • (2010) Sci China Life Sci , vol.53 , pp. 683-689
    • Zhu, F.X.1    Liu, Z.L.2    Chi, X.Y.3
  • 10
    • 34548796475 scopus 로고    scopus 로고
    • The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene
    • Chen L X, Zhu F X, Li J, et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther, 2007, 15: 1856-1862.
    • (2007) Mol Ther , vol.15 , pp. 1856-1862
    • Chen, L.X.1    Zhu, F.X.2    Li, J.3
  • 11
    • 59649122961 scopus 로고    scopus 로고
    • Long-term correction of inhibitor-prone hemophilia B dogs treated with liver directed AAV2-mediated factor IX gene therapy
    • Niemeyer G P, Herzog R W, Mount J, et al. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver directed AAV2-mediated factor IX gene therapy. Blood, 2009, 113: 797-806.
    • (2009) Blood , vol.113 , pp. 797-806
    • Niemeyer, G.P.1    Herzog, R.W.2    Mount, J.3
  • 12
    • 77954245040 scopus 로고    scopus 로고
    • Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B
    • Arruda V R, Stedman H H, Haurigot V, et al. Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B. Blood, 2010, 115: 4678-4688.
    • (2010) Blood , vol.115 , pp. 4678-4688
    • Arruda, V.R.1    Stedman, H.H.2    Haurigot, V.3
  • 13
    • 0023918719 scopus 로고
    • Synthesis, processing, and secretion of recombinant human factor VI11 expressed in mammalian cell
    • Kaufman R J, Wasley L C, Dorner A J. Synthesis, processing, and secretion of recombinant human factor VI11 expressed in mammalian cell. J Biol Chem, 1988, 263: 6352-6362.
    • (1988) J Biol Chem , vol.263 , pp. 6352-6362
    • Kaufman, R.J.1    Wasley, L.C.2    Dorner, A.J.3
  • 14
    • 0032697618 scopus 로고    scopus 로고
    • Biochemistry and physiology of blood coagulation
    • Mann K G. Biochemistry and physiology of blood coagulation. Thromb Haemost, 1999, 82: 165-174.
    • (1999) Thromb Haemost , vol.82 , pp. 165-174
    • Mann, K.G.1
  • 15
    • 0030821993 scopus 로고    scopus 로고
    • Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII
    • Swaroop M, Moussalli M, Pipe S W, et al. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J Biol Chem, 1997, 272: 24121-24124.
    • (1997) J Biol Chem , vol.272 , pp. 24121-24124
    • Swaroop, M.1    Moussalli, M.2    Pipe, S.W.3
  • 16
    • 0024404910 scopus 로고
    • Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells
    • Dorner A J, Wasley L C, Kaufman R J. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J Biol Chem, 1989, 264: 20602-20607.
    • (1989) J Biol Chem , vol.264 , pp. 20602-20607
    • Dorner, A.J.1    Wasley, L.C.2    Kaufman, R.J.3
  • 17
    • 32044453080 scopus 로고    scopus 로고
    • Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response
    • Zhang K, Shen X, Wu J, et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell, 2006, 124: 587-599.
    • (2006) Cell , vol.124 , pp. 587-599
    • Zhang, K.1    Shen, X.2    Wu, J.3
  • 18
    • 61649128763 scopus 로고    scopus 로고
    • Enhanced factor VIII heavy chain for gene therapy of hemophilia A
    • Chen L X, Lu H, Wang J H, et al. Enhanced factor VIII heavy chain for gene therapy of hemophilia A. Mol Ther, 2009, 17: 417-424.
    • (2009) Mol Ther , vol.17 , pp. 417-424
    • Chen, L.X.1    Lu, H.2    Wang, J.H.3
  • 19
    • 9144271163 scopus 로고    scopus 로고
    • Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to vWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development
    • d'Oiron R, Lavergne J M, Lavend'homme R, et al. Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to vWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development. Blood, 2004, 103: 155-157.
    • (2004) Blood , vol.103 , pp. 155-157
    • d'Oiron, R.1    Lavergne, J.M.2    Lavend'homme, R.3
  • 20
    • 0025923490 scopus 로고
    • Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit
    • Fay P J, Haidaris P J, Smudzin T M. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem, 1991, 266: 8957-8962.
    • (1991) J Biol Chem , vol.266 , pp. 8957-8962
    • Fay, P.J.1    Haidaris, P.J.2    Smudzin, T.M.3
  • 21
    • 0025748557 scopus 로고
    • The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII
    • Wise R J, Dorner A J, Krane M, et al. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem, 1991, 266: 21948-21955.
    • (1991) J Biol Chem , vol.266 , pp. 21948-21955
    • Wise, R.J.1    Dorner, A.J.2    Krane, M.3
  • 22
    • 79952194475 scopus 로고    scopus 로고
    • Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors
    • Sabatino D S, Lange A M, Altynova E S, et al. Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors. Mol Ther, 2011, 19: 442-449.
    • (2011) Mol Ther , vol.19 , pp. 442-449
    • Sabatino, D.S.1    Lange, A.M.2    Altynova, E.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.